ライフサイエンスコーパス: vital sign

1 f 5,321 patients presented severely abnormal vital signs.

2 curred simultaneously with outliers in other vital signs.

3 asurements were linked to routinely measured vital signs.

4 rhage that present as severe derangements of vital signs.

5 dence of the nonrepresentativeness of hourly vital signs.

6 d with the Early Warning Score only based on vital signs.

7 392 (27.4%) patients from arrival to time of vital signs.

8 relevant changes in blood pressure or other vital signs.

9 higher creatinine levels and less favorable vital signs.

10 lder age, abnormal blood tests, and abnormal vital signs.

11 tion by monitoring the patient condition and vital signs.

12 opinion in individual hospitals and only use vital signs.

13 cale, the Mini-Mental State Examination, and vital signs.

14 euphoria, cognitive deficits, or changes in vital signs.

15 ospital trauma patients with normal standard vital signs.

16 essions, most commonly a transient change in vital signs.

17 ion of electrocardiograms, and assessment of vital signs.

18 te +/- 11, P < .001), there was no effect on vital signs.

19 y but particularly with indirect measures of vital signs.

20 bidity and mortality, beyond the traditional vital signs.

21 Score, Injury Severity Score, and admission vital signs.

22 speeds, dyskinesia, subjective effects, and vital signs.

23 e duration of ice hockey seasons using brain vital signs.

24 thout any acute adverse events or changes in vital signs.

25 Analysis of variance was used to compare vital signs.

26 adverse experiences, physical examinations, vital signs, 12-lead electrocardiogram, and laboratory s

27 ical (17%) and abnormal laboratory values or vital signs (17%).

28 of cardiac medications, (2) self-tracking of vital signs, (3) education about cardiovascular disease

29 ospital trauma patients with normal standard vital signs (32 LSI patients, 127 No-LSI patients).

30 dose safety assessments included orthostatic vital signs; 6-lead continuous telemetry monitoring (app

31 days later in severe distress, with unstable vital signs, a jaundiced appearance, and substantial pai

32 Other assessments included vital signs, a physical examination, and 12-lead electro

33 lts, pneumonia is uncommon in the absence of vital sign abnormalities or asymmetrical lung sounds, an

34 unity-acquired pneumonia, but the absence of vital sign abnormalities substantially reduces the proba

35 Vital sign abnormalities such as fever (temperature >37.

36 incidence of adverse events or laboratory or vital sign abnormalities were observed between groups.

37 incidences of adverse events, laboratory, or vital sign abnormalities were observed between groups.

38 ness; 3 or more CABP symptoms; and 2 or more vital sign abnormalities.

39 nitored for predefined, standardized, acute, vital-sign abnormalities or marked nursing concern.

40 tent, provided intravenous access, monitored vital signs, administered lethal injections and declared

41 There were no systematic changes in vital signs after ferumoxytol administration (P > .05).

42 se, concentrating on donor factors including vital signs after withdrawal of support.

43 Vital signs, age, BMI, dyspnea, and comorbidities were t

44 termine whether implementation of the CRADLE Vital Sign Alert and an education package into community

45 cations included: oxygen desaturations <90%, vital sign alterations requiring intervention, rashes, s

46 We analyzed 146 patient-years of vital sign and electrocardiography waveform time series

47 The use of temporal vital signs and a single measurement of serum biomarkers

48 Differences between baseline model estimated vital signs and actual monitored values were used to tri

49 Laboratory model supplemented with admission vital signs and additional laboratory data (VS model), V

50 ents, electrocardiography, and monitoring of vital signs and body weight.

51 gns monitors to assist in the acquisition of vital signs and calculation of early warning scores.

52 r side effects and gained less weight; other vital signs and cardiometabolic laboratory findings did

53 Despite changes in vital signs and catecholamine levels during sedative int

54 Vital signs and composite scores, such as the Modified E

55 During this time, vital signs and electrocardiograms were recorded at regu

56 performed similarly with regard to improving vital signs and gas exchange and avoiding intubation, th

57 y predictors of G6PD deficiency by analyzing vital signs and hematocrit and by asking screening quest

58 common operative procedures, 62% had normal vital signs and hematocrit readings before transfusion.

59 Vital signs and hematologic and biochemical parameters w

60 Measurement of vital signs and hormones during a 24-hr period.

61 Alum-adjuvanted hepatitis B vaccine elicited vital signs and inflammatory (CRP/innate cells) response

62 Vital signs and laboratory results were collected before

63 clinical assessment, including the review of vital signs and laboratory tests.

64 al Organ Failure Assessment risk scores from vital signs and laboratory values documented during the

65 Vital signs and laboratory values were collected to defi

66 Significant changes in vital signs and laboratory values were evaluated by usin

67 Of the individual vital signs and labs, maximum respiratory rate was the m

68 to 2014 were matched with enterprise data on vital signs and neurologic status to calculate the EWS f

69 patients may require frequent monitoring of vital signs and nursing interventions but usually do not

70 njury data, admission laboratory values, and vital signs and outcomes including mortality, tempo of t

71 n an epidemic was developed using only those vital signs and patient characteristics that were readil

72 rmal values, then correlated with changes in vital signs and pharmacologic interventions.

73 stment of ultrafiltration rates to patients' vital signs and renal function may be associated with mo

74 timeliness and low burden and therefore used vital signs and routine laboratory tests, had the greate

75 fol infusion was titrated to maintain stable vital signs and sedative levels.

76 Data on other vital signs and self-reported health measures were obtai

77 The effects of (3)He MR imaging on vital signs and Spo(2) and the relationship between pulm

78 Patients with severely deviating vital signs and suspected infection were triaged into a

79 Opacities on chest imaging, age, admission vital signs and symptoms, male gender, admission laborat

80 laboratory values were more predictive than vital signs and the average length of stay in an long-te

81 receiver operating characteristic curve for vital signs and the Modified Early Warning Score were al

82 iver operating characteristic curves for all vital signs and the Modified Early Warning Score were hi

83 ey require early detection by measurement of vital signs and timely administration to save lives.

84 aimed to derive new centile charts for these vital signs and to compare these centiles with existing

85 ravenous hydration; systematic monitoring of vital signs and volume status; availability of key bioch

86 tibiotic treatment, liver disease, and three vital-sign and three laboratory abnormalities.

87 Clinical laboratory, electrocardiograms, vital signs, and adverse event monitoring comprised the

88 adverse events, clinical laboratory values, vital signs, and anti-AMG 334 antibodies.

89 adverse events, clinical laboratory values, vital signs, and anti-erenumab antibodies.

90 included treatment-emergent adverse events, vital signs, and change in weight.

91 kidney volume, GFR, quality of life, safety, vital signs, and clinical laboratory tests.

92 Laboratory results, vital signs, and demographics were used as predictor var

93 Demographics, vital signs, and injury severity were recorded.

94 odel, adjusting for demographics, mechanism, vital signs, and injury severity.

95 of death, exceeding comorbidities, abnormal vital signs, and laboratory test abnormalities.

96 sence of organ dysfunction, abnormalities in vital signs, and major infections.

97 otypes that include laboratory data, images, vital signs, and other clinical information.

98 sion functional status, comorbid conditions, vital signs, and other physiological indices), hyperoxia

99 laboratory assessments, electrocardiograms, vital signs, and physical examination; secondary measure

100 Sepsis-induced changes in activity, vital signs, and pituitary hormones are modulated by the

101 graphics, baseline comorbidities, presenting vital signs, and test results were also collected.

102 facilities, replicated patient notes, active vital signs, and the ability to contact surgical or anes

103 l ventilator settings, arterial blood gases, vital signs, and use of vasopressors were collected from

104 ales, laboratory values, electrocardiograms, vital signs, and weight change.

105 g organ dysfunction, proportional changes in vital signs, anemia, and quantifiable bleeding.

106 ystolic blood pressure was the most accurate vital sign (area under the receiver operating characteri

107 e steady state with measurements of baseline vital signs, arterial blood gases, and ventilatory setti

108 n rate, energy intensity and other essential vital signs, as well as talking time and cadence, swallo

109 ratory abnormalities, electrocardiogram, and vital sign assessments.

110 Vital signs at admission and laboratory data may be usef

111 Data were collected on vital signs at admission to the ICU, patient characteris

112 d combat hospitals, cohorts of patients with vital signs at presentation and subsequent in-hospital d

113 ons, and indications for the test as well as vital signs at rest and under stress and the symptoms an

114 stituting regular pain assessment (pain as a vital sign), audit of pain results and feedback to clini

115 Current vital sign-based risk scores for ward patients have demo

116 ur, little is known about the differences in vital signs between elderly and nonelderly patients prio

117 training data-sets of pre-/post-vaccination vital signs, blood changes and whole-blood gene transcri

118 d expensive to collect clinical data such as vital signs, blood culture results, key clinical finding

119 Vital signs, blood samples, electrocardiographs (ECGs),

120 Among vital signs, body temperature was best at predicting mor

121 ents at risk, particularly those with normal vital signs but ongoing, occult hypoperfusion.

122 Serial evaluations of vital signs, cardiorespiratory parameters, blood culture

123 Vital signs, catecholamine levels, and time with ischemi

124 Although age-related vital sign changes are known to occur, little is known a

125 e in blood levels of inflammatory cytokines, vital sign changes, and sickness symptoms, well-establis

126 Secondary outcomes included vital sign changes, soft-tissue anesthesia, and treatmen

127 oted no substantial changes from baseline in vital signs, clinical laboratory findings, or electrocar

128 nts, physical and neurological examinations, vital signs, clinical laboratory tests, cerebrospinal fl

129 dynamic cluster, end-organ function cluster, vital-sign cluster, complete blood count and sodium clus

130 unication are giving rise to new methods for vital sign data analysis and a new generation of transpo

131 diovascular, and neurological function using vital sign data from the FEAST trial, and used them to c

132 s as real or artifacts in online noninvasive vital sign data streams to reduce alarm fatigue and miss

133 Vital sign data were abstracted from individual patient

134 S criteria based on admission laboratory and vital sign data were considered to have SIRS.

135 synchronize exponentially growing amounts of vital sign data with electronic patient care information

136 be necessary for creating a valid archive of vital sign data within an electronic medical record.

137 ysis, and looked for potential errors in the vital sign data.

138 We used the vital sign day as our unit of measurement, defined as al

139 We found that 15-38% of vital sign days contained at least one statistical outli

140 Approximately 30-40% of vital sign days included at least one gap of greater tha

141 imetry vital sign days, the readings in most vital sign days were normally distributed.

142 With the exception of pulse oximetry vital sign days, the readings in most vital sign days we

143 ime required to complete and record a set of vital signs decreased from 4.1+/-1.3 mins to 2.5+/-0.5 m

144 Vital sign, demographic, location, and laboratory data w

145 Among HL measures, the Newest Vital Sign demonstrated a significant relationship with

146 ly meaningful abnormalities were apparent on vital sign determinations, laboratory findings, or elect

147 Alerts were vital sign deviations beyond stability thresholds.

148 This trial implemented a novel vital sign device and training package in routine matern

149 as well tolerated, with no marked effects on vital signs, ECG readings, or laboratory values.

150 re were no clinically significant changes in vital signs, ECGs, or clinical chemistry laboratory valu

151 Clinical assessment (including vital signs, echocardiograms, and electrocardiographs) a

152 ents consisted of monitoring adverse events, vital signs, electrocardiogram and laboratory results, a

153 tions included monitoring of adverse events, vital signs, electrocardiogram results, and clinical lab

154 AZD3241 included records of adverse events, vital signs, electrocardiogram, and laboratory tests.

155 No clinically significant changes in vital signs, electrocardiogram, or laboratory values wer

156 revealed no clinically meaningful changes in vital signs, electrocardiogram, or laboratory values.

157 rse events (AEs), clinical laboratory tests, vital signs, electrocardiograms, and validated scales.

158 During this time, standard vital signs, electrocardiographic (ECG) readings, and bl

159 There were no changes in vital signs, electrocardiographic findings, or laborator

160 Data on vital signs, electrolytes, arterial blood gases, and coa

161 ociated with clinically important changes in vital signs, electrolytes, arterial blood gases, or coag

162 Among multi-item measures, the Newest Vital Sign (English) performed moderately well for ident

163 , p<0.0001), and having one or more affected vital signs (fever, hypotension, tachycardia, or tachypn

164 ) for peripheral oximetry at the instant the vital sign first crossed threshold and increased to 0.87

165 ervational study of continuous monitoring of vital signs for 30 minutes after the clinical determinat

166 We aimed to compare the accuracy of vital signs for detecting cardiac arrest between elderly

167 vital signs, supporting nurses by measuring vital signs frequently and accurately.

168 n of calls secondary to abnormal respiratory vital signs (from 21% to 31%; difference [95% confidence

169 (eg, a single data domain like medication or vital signs) given the same training size; (2) as data q

170 with adverse events, laboratory values, and vital signs graded according to the Common Terminology C

171 The EWS calculated using vital signs has been developed to identify patients at r

172 le sensors measuring physical parameters for vital signs have been developed.

173 r wearable devices that continuously measure vital signs have been used to monitor the onset of infec

174 om 2008 to 2014 were merged with laboratory, vital sign, health care utilization, and postoperative c

175 In the absence of abnormalities in vital signs (heart rate > 100 beats/min, respiratory rat

176 A simple risk index based on age and vital signs (heart rate x [age/10](2)/systolic blood pre

177 Blood samples were collected, and standard vital signs (heart rate, pulse oximetry, and body temper

178 sis of MNA include incorporation of MNA as a vital sign in daily clinical practice, self-reporting us

179 valuate a simple risk index based on age and vital signs in a community sample of patients with ST-se

180 d on the skin can be valuable for monitoring vital signs in emergency care, detecting the early onset

181 Fundamental approaches to assessing vital signs in the critically ill have changed little si

182 g optimal sampling frequencies for recording vital signs in the ICU.

183 measurement and consider it as an important 'vital sign' in clinical practice.

184 t Commission recommended making pain the 5th vital sign, increasing the focus on postoperative pain c

185 complaint, admission diagnosis, and abnormal vital signs into bivariate and nested multivariate model

186 Demographics, comorbidities, vital signs, laboratory data, and ACEi/ARB usage were an

187 adverse events (AEs), physical examinations, vital signs, laboratory parameters, and electrocardiogra

188 Adverse events, vital signs, laboratory parameters, and electrocardiogra

189 No clinically significant abnormalities in vital signs, laboratory results, or electrocardiogram fi

190 e primary outcome and included assessment of vital signs, laboratory tests, and serial eye examinatio

191 ied: demographics, comorbidity, medications, vital signs, laboratory tests, severity, and symptoms.

192 Vital signs, laboratory values, and Acute Physiology and

193 of information to make decisions, including vital signs, laboratory values, and entries in the medic

194 Demographic data, vital signs, laboratory values, injury severity score, a

195 Demographic characteristics, vital signs, laboratory values, nursing flowsheet data,

196 were no significant differences detected in vital signs, laboratory values, procedures, treatment, o

197 All subjects were monitored for vital signs, laboratory variables, and adverse events.

198 ere monitored for adverse events; changes in vital signs, laboratory variables, and the results of mi

199 ier models using 24 variables (demographics, vital signs, laboratory, and respiratory variables) at e

200 No clinically significant vital signs, laboratory, or electrocardiogram findings w

201 There were no clinically relevant changes in vital signs, laboratory, or electrocardiogram parameters

202 Procedural monitoring included vital signs, left atrial pressure, arterial blood pressu

203 Vital signs, lipids, and laboratory parameters at 12 and

204 es, interpreted in conjunction with standard vital signs, may contribute to earlier assessments of th

205 The Mini-Cog is an ultrashort cognitive "vital signs" measure that has not been studied in patien

206 ysical examination that includes orthostatic vital signs measured in both recumbent and vertical posi

207 team calls, and decreased time required for vital signs measurement and recording (NCT01197326).

208 e respective values became obvious by manual vital signs measurement.

209 mination including laboratory assessment and vital sign measurements, and at low risk of HIV infectio

210 identified primary and secondary diagnoses, vital sign measurements, length of stay (LOS), hospital

211 t number of missing, erroneous, and outlying vital signs measurements in a large ICU database.

212 luding hand hygiene, isolation of infection, vital signs, medication delivery, and hand off.

213 ed information on demographics, comorbidity, vital signs, medications, and left ventricular systolic

214 irst appearance in the record of an abnormal vital sign meeting rapid response team criteria and the

215 Noninvasive vital sign monitoring data (heart rate, respiratory rate

216 Existing vital sign monitoring systems in the neonatal intensive

217 to extract cardiac parameters for continuous vital sign monitoring.

218 Studies were included if they evaluated vital signs monitoring in adult human subjects.

219 se series illustrates that a wireless remote vital signs monitoring system on medical and surgical wa

220 ropean countries installed a remote wireless vital signs monitoring system on medical or surgical war

221 taneous sweat sampling, chemical sensing and vital-sign monitoring.

222 Electronic automated advisory vital signs monitors may help identify such patients and

223 We deployed electronic automated advisory vital signs monitors to assist in the acquisition of vit

224 Deployment of electronic automated advisory vital signs monitors was associated with an improvement

225 deployment of electronic automated advisory vital signs monitors.

226 Vital signs more accurately detect cardiac arrest in non

227 Loss of vital signs occurred at the scene in 48.1%, en-route in

228 or changes in clinical laboratory values or vital signs occurred during this study.

229 Respiration signals are a vital sign of life.

230 lectrochemical sensor to monitor biochemical vital signs of health such as the glucose level in sweat

231 e the progression of LO projects so that the vital signs of LO convergence can be monitored.

232 Vital signs of porcine animals were continuously monitor

233 ell tolerated, without noticeable changes in vital signs, on electrocardiograms, or in laboratory val

234 ns were recorded through day 10 and included vital signs, onset of organ dysfunction, clinical labora

235 ere obtained along with a scheduled check of vital signs or for clinical suspicion of deterioration)

236 There were no differences in vital signs or laboratory safety data between the two tr

237 t gain nor clinically significant changes in vital signs or other safety parameters were observed wit

238 identified 10 studies investigating postural vital signs or the capillary refill time of healthy volu

239 dizziness (preventing measurement of upright vital signs) or a postural pulse increment of 30 beats/m

240 tients, scarring was unrelated to mortality, vital signs, or clinical symptoms but those with scarrin

241 report the effect of ibuprofen treatment on vital signs, organ failure, and mortality in hypothermic

242 ordings from a single patient for a specific vital sign over a single 24-hour period.

243 demographics, outpatient asthma medications, vital signs, oxygen saturation, and forced expiratory vo

244 Secondary outcomes included vital signs, oxygen saturation, hospitalization, physici

245 No significant changes in vital signs (P > .27) were observed, and no subjects exh

246 and delayed latency scores for all six brain vital signs (P < 0.0001).

247 vs 11 [24%] of 46 patients without affected vital signs, p=0.02).

248 differences in markers of systemic effects (vital signs, potassium, and blood glucose concentrations

249 Patient characteristics and vital signs prior to cardiac arrest were compared betwee

250 om 2008 to 2014 were merged with laboratory, vital signs, prior healthcare utilization, and postopera

251 hypertensive medications, recorded symptoms, vital signs, radiographic findings, and laboratory value

252 Most vital sign readings fell into realistic ranges, with man

253 Patients in both groups had vital signs recorded after the first trigger, at 20 min

254 emedicine was 86% for basic health sessions (vital sign recording), but only 45% for using messaging

255 rns varied by less than 0.8 degrees C, their vital signs remained stable, and no complications were e

256 able technology (eg, to monitor activity and vital signs), remote patient monitoring (eg, environment

257 nically significant changes were observed in vital signs, routine laboratory values, weight, metaboli

258 the effects of these factors along with the vital sign scores on the contribution of bolus to mortal

259 significant dose-related adverse effects on vital signs, serum chemistries, ECGs, or adverse events

260 fety and toxicity were measured by comparing vital signs, serum chemistry values, or acquisition-rela

261 ncy team criteria to a database of 2,245,778 vital signs sets (103,998 admissions).

262 Laboratory data, vital signs, slit lamp examination, best-corrected dista

263 was time to clinical response-a composite of vital sign stabilisation and hospital discharge-in the i

264 Clinical stability was defined based on vital sign stabilization, described in the American Thor

265 edical devices designed for monitoring human vital signs, such as body temperature, heart rate, respi

266 s the continuous recording of ward patients' vital signs, supporting nurses by measuring vital signs

267 and blood pressure, respiratory rate is the vital sign that has been often overlooked, largely due t

268 n summary, gait speed is an easily obtained "vital sign" that accurately identifies frailty and predi

269 Asthma control is an important "vital sign" that may be useful both for population-based

270 Safety measurements included adverse events, vital signs, the Abnormal Involuntary Movement Scale, th

271 rs that mainly track physical activities and vital signs, the new generation of wearable and flexible

272 We recorded initial vital signs, the source of infection, mortality at 28 da

273 Injection of orexin-A increased vital signs to baseline levels.

274 that adding the Early Warning Score based on vital signs to the DENWIS-indicators improves prediction

275 phasis on the status of behavior as a "sixth vital sign" to be assessed in all cancer patients throug

276 everal fields, including sensors, actuators, vital sign transducers, and energy harvesters.

277 d, for a subset of patients, high-resolution vital sign trends and waveforms.

278 evoked potential framework to extract 'brain vital signs' using electroencephalography.

279 noea; 96 [44%] of 217 patients with affected vital signs vs 11 [24%] of 46 patients without affected

280 Brain vital signs were derived from well established evoked re

281 e time from patient arrival to the time when vital signs were first recorded was used as a proxy for

282 Core temperature and vital signs were measured at baseline and at 5-15-minute

283 r 48 hours post-cecal ligation and puncture, vital signs were measured, and1 microL of saline with or

284 nt groups based on mean values when standard vital signs were normal.

285 No clinically relevant changes in ECGs or vital signs were noted.

286 any of 21 common antipsychotic side effects, vital signs were obtained, fasting blood samples were co

287 Vital signs were recorded and serial blood samples analy

288 Vital signs were recorded over 30 min during the imaging

289 Vital signs were repeated at 25 or 49 hours post-cecal l

290 onsumption, fibrin degradation products, and vital signs were similar between the animals infused wit

291 red after placebo or MSG administration, and vital signs were stable.

292 Changes in vital signs were tested for significance across subject

293 emographic variables, laboratory values, and vital signs were utilized in a discrete-time survival an

294 pon arrival in the emergency department, her vital signs were within normal limits, and an electrocar

295 those during the 7 AM hour had more deranged vital signs, were more likely to have a respiratory trig

296 rolonged sedation and amnesia and stabilized vital signs while significantly decreasing diazepam and

297 rated significant, time-dependent changes in vital signs, white blood cell counts, inflammatory cytok

298 pectively) involves continuous monitoring of vital signs with hard-wired devices that adhere to the s

299 Safety assessment included measurements of vital signs with regular intervals during the imaging se

300 tology, coagulation, urinalysis, orthostatic vital signs, WSF, or 12-lead ECG parameters.